Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies

Respiration

Volumn 91, Issue 1, 2016, Pages 3-8

  Kreuter, Michael ^a,e   Kirsten, Detlef ^f,g   Bahmer, Thomas ^f,g   Penzel, Roland ^c   Claussen, Martin ^f,h   Ehlers Tenenbaum, Svenja ^a   Muley, Thomas ^b,e   Palmowski, Karin ^a   Eichinger, Monika ^d   Leider, Marta ^h   Herth, Felix J F ^a,e   Rabe, Klaus F ^f,h   Bittmann, Iris ^h   Warth, Arne ^c,e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Translational Research Unit   (Germany)

^c Institute of Pathology   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e German Center for Lung Research   (Germany)

^f LungenClinic   (Germany)

^g GERMAN CENTER FOR LUNG RESEARCH   (Germany)

^h Institute of Pathology   (Germany)

Author keywords

Gastro oesophageal reflux disease; Helicobacter pylori; Idiopathic pulmonary fibrosis; Lung biopsy; Polymerase chain reaction

Indexed keywords

BACTERIAL DNA; CARBON MONOXIDE; CORTICOSTEROID; PROTON PUMP INHIBITOR; RNA 16S;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; HUMAN TISSUE; LUNG ASPIRATION; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG MICROASPIRATION; LUNG TRANSPLANTATION; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; TOTAL LUNG CAPACITY; TRANSBRONCHIAL BIOPSY; VITAL CAPACITY; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; DISEASE COURSE; FACTUAL DATABASE; GERMANY; HELICOBACTER INFECTIONS; HERNIA, HIATAL; IDIOPATHIC PULMONARY FIBROSIS; ISOLATION AND PURIFICATION; LUNG; LUNG DIFFUSION CAPACITY; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SLEEP APNEA SYNDROMES;

AGED; BIOPSY; CASE-CONTROL STUDIES; COMORBIDITY; DATABASES, FACTUAL; DISEASE PROGRESSION; DNA, BACTERIAL; FEMALE; GASTROESOPHAGEAL REFLUX; GERMANY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MASS SCREENING; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTON PUMP INHIBITORS; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SLEEP APNEA SYNDROMES; VITAL CAPACITY;

EID: 84955647166     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000442449     Document Type: Article

References (33)

1. Raghu G, Collard HR, Egan JJ, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
2. Ley B, Collard HR, King TE Jr: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431-440.
3. Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE Jr: Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 2010;123:304-311.
4. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA: High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-142.
5. Mays EE, Dubois JJ, Hamilton GB: Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976;69:512-515.
6. Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G: Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804-1808.
7. Hershcovici T, Jha LK, Johnson T, Gerson L, Stave C, Malo J, Knox KS, Quan S, Fass R: Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011;34:1295-1305.
8. Noth I, Zangan SM, Soares RV, Forsythe A, Demchuk C, Takahashi SM, Patel SB, Strek ME, Krishnan JA, Patti MG, Macmahon H: Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J 2012;39:344-351.
9. Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, Sugarbaker DJ, Bueno R: Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006;131:438-446.
10. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE Jr, Collard HR: Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:1390-1394.
11. Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G; IPFnet Investigators: Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013;1:369-376.
12. Idiopathic Pulmonary Fibrosis Clinical Research Network; Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW: A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010;363:620-628.
13. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA; Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:88-95.
14. Idiopathic Pulmonary Fibrosis Clinical Research Network; Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-1977.
15. Ibrahim WH: Helicobacter pylori eradication in the management of idiopathic pulmonary fibrosis. Eur Respir J 2007;30:395-396.
16. Kanbay M, Kanbay A, Boyacioglu S: Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med 2007;101:203-209.
17. Adriani A, Repici A, Hickman I, Pellicano R: Helicobacter pylori infection and respiratory diseases: actual data and directions for future studies. Minerva Med 2014;105:1-8.
18. Westhoff M: Acute on chronic respiratory failure in interstitial pneumonias (in German). Med Klin Intensivmed Notfmed 2015;110:188-196.
19. Collard HR, Moore BB, Flaherty KR, et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators: Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:636-643.
20. Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, Johnson GE, Dark JH, Pearson JP, Ward C: Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med 2007;175:1298-1303.
21. Michel A, Pawlita M, Boeing H, Gissmann L, Waterboer T: Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathog 2014;6:10.
22. Bennett D, Bargagli E, Refini RM, Campagna MS, Gennari L, Nuti R, Figura N, Rottoli P: Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis. Eur Respir J 2014;43:635-638.
23. Hogaboam C: Pathogenesis of IPF. 6th WASOG Conf, June 6-7, 2013, Paris.
24. Nakashima S, Kakugawa T, Yura H, Tomonaga M, Harada T, Hara A, Hara S, Nakano M, Yamasaki E, Sakamoto N, Ishimatsu Y, Isomoto H, Gochuico BR, Suffredini AF, Mukae H, Kurazono H, Hirayama T, Moss J, Kohno S: Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. Biochem Biophys Res Commun 2015;460:721-726.
25. Prasse A, Binder H, Jäger B, Schupp J, Bargagli E, Vuga L, Lynn H, Herazo-Mayo J, Rottoli P, Wuyts W, Kaminski N: BAL signature predictive of mortality in idiopathic pulmonary fibrosis is highly enriched for airway basal cell genes. ICLAF 2014, 18th International Colloquium on Lung and Airway Fibrosis, 2014. http://www.iclaf.com/conference/index.php/2014/ICLAF/paper/view/48>.
26. Kuranishi LT, Leslie KO, Ferreira RG, Coletta EA, Storrer KM, Soares MR, de Castro Pereira CA: Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis. Respir Res 2015;16:55.
27. Gülhan M, Ozyilmaz E, Tarhan G, Demiraʇ F, Capan N, Ertürk A, Canbakan S, Ayaşlioʇlu E, Gülhan E, Ahmed K: Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue. Arch Med Res 2007;38:317-321.
28. Ilvan A, Ozturkeri H, Capraz F, Cermik H, Kunter E: Investigation of Helicobacter pylori in bronchoscopic lung specimens of young male patients with bronchiectasis but without gastrointestinal symptoms. Clin Microbiol Infect 2004;10:257-260.
29. Samareh Fekri M, Hashemi Bajgani SM, Rasti A, Yazdani R, Mollaie HR: Detection of Helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction. Jundishapur J Microbiol 2014;8:e14551.
30. Sze MA, Chen YW, Tam S, Tashkin D, Wise RA, Connett JE, Man SP, Sin DD: The relationship between Helicobacter pylori seropositivity and COPD. Thorax 2015;70:923-929.
31. Salama NR, Hartung ML, Müller A: Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol 2013;11:385-399.
32. Mitz HS, Farber SS: Demonstration of Helicobacter pylori in tracheal secretions. J Am Osteopath Assoc 1993;93:87-91.
33. Kariya S, Okano M, Nishizaki K: An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction? World J Gastroenterol 2014;20:1470-1484.